Compound information
- Natural Products
- ZC1046080
- Molecular Formula
- C20H24N4O8S2
- Molecular Weight
- 512.103555728 g/mol
- Structure
-
- IUPAC Name
- methyl N-[4-[4-[4-(methoxycarbonylamino)phenyl]sulfonylpiperazin-1-yl]sulfonylphenyl]carbamate
- InChI
- InChI=1S/C20H24N4O8S2/c1-31-19(25)21-15-3-7-17(8-4-15)33(27,28)23-11-13-24(14-12-23)34(29,30)18-9-5-16(6-10-18)22-20(26)32-2/h3-10H,11-14H2,1-2H3,(H,21,25)(H,22,26)
- InChI Key
- UYYMUUIHIZMWGE-UHFFFAOYSA-N
- SMILES
- COC(=O)Nc1ccc(S(=O)(=O)N2CCN(S(=O)(=O)c3ccc(NC(=O)OC)cc3)CC2)cc1
- Source
- ZINC000012533265
Warheads
- Carbamate
-
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 34 | Ring Count | 3 |
Heteroatom Count | 14 | Rotatable Bond Count | 6 |
Hydrogen Bond Acceptor Count | 8 | Hydrogen Bond Donor Count | 2 |
Topological Polar Surface Area | 151.42 Å2 | LogP | 1.836 |
LogS | -4.718 | LogD | 2.467 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.008 | Pgp substrate | 0.951 |
HIA | 0.95 | F20 % | 0.991 |
F30 % | 0.004 | Caco-2 | -4.776 |
MDCK | -5.358 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.005 | PPB | 99.599 |
VD | 0.86 | Fu | 1.628 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.1 | CYP1A2 substrate | 0.481 |
CYP2A6 substrate | 0.335 | CYP2B6 substrate | 0.527 |
CYP2C19 inhibitor | 0.249 | CYP2C19 substrate | 0.732 |
CYP2C8 substrate | 0.859 | CYP2C9 inhibitor | 0.488 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.719 |
CYP2D6 substrate | 0.597 | CYP2E1 substrate | 0.38 |
CYP3A4 inhibitor | 0.056 | CYP3A4 substrate | 0.988 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.201 | CL | 5.751 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.284 | Hepatotoxicity | 0.979 |
Mutagenicity | 0.004 | Rat Oral Acute Toxicity | 0.046 |
FDAMDD | 0.096 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.054 | Eye Corrosion | 0.001 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.018 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.54 | IGC50 | 3.77 |
LC50FM | -4.765 | LC50DM | -4.907 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.057 | NR-AR-LBD | 0.372 |
NR-AhR | 0.071 | NR-Aromatase | 0.178 |
NR-ER | 0.316 | NR-ER-LBD | 0.402 |
NR-PPAR-gamma | 0.191 | SR-ARE | 0.757 |
SR-ATAD5 | 0.327 | SR-HSE | 0.037 |
SR-MMP | 0.198 | SR-p53 | 0.147 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.